|Day Low/High||47.38 / 47.66|
|52 Wk Low/High||38.05 / 50.22|
Generic drugmakers are likely to limit themselves to acquisitions of small- and mid-sized companies in the immediate future because of over-leveraging and turmoil in the executive ranks..
Fresenius Medical Care North America (FMCNA), the nation's leading renal care company, announces a company-wide national team in support of the National Kidney Foundation's (NKF) annual Kidney Walk, the nation's largest...
FreseniusRx, a nationwide pharmacy focused on medication access and adherence for patients on dialysis, announced today that it has named Randell (RJ) Correia, PharmD, as its new President.
Fresenius Medical Care AG & Co. KGaA ("the company" or "Fresenius Medical Care"), the world's largest provider of dialysis products and services, announced that it has filed the annual report 2016 under form 20-F with...
Unease over the outlook for global trade, monetary policies and politica stability torpedoed markets from early on Tuesday
Acumen Physician Solutions, a subsidiary of Fresenius Medical Care North America (FMCNA), today announced that it has joined forces with Epic Systems Corporation to develop Acumen 2.
Fresenius Medical Care North America (FMCNA), a division of Fresenius Medical Care (NYSE: FMS), announced today that it is joining forces with Humana Inc.
Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Fresenius Medical Care AG & Co.
Levi & Korsinsky, LLP is investigating Fresenius Medical Care AG & Co.
A possible merger between Nestle and Mead Johnson could trigger anti-trust concerns.
Fresenius Medical Care North America, the country's leading provider of kidney care products and services, announced today that the Centers for Medicare & Medicaid Services (CMS) has awarded it contracts to operate 18...
European health care and pharmaceutical company shares were hit hard Thursday after President-elect Donald Trump accused some firms of 'getting away with murder' in his Wednesday press conference.
European stocks fell across the board in early Wednesday trading as investors adopt a defensive tone ahead of the first major press conference for President-elect Donald Trump.
Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of Fresenius Medical Care AG & Co.
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Fresenius Medical Care AG & Co.
The medical supplies maker says it's cooperating with a federal investigation.
A new state-of-the-art dialysis center is opening soon on Cleveland's East Side.
People with kidney failure in Baltimore and the surrounding area can now access dialysis treatments and a full spectrum of enhanced kidney care services at eight new care centers, all through a collaboration between...
Hemodialysis patients who skipped the influenza vaccine were significantly more likely to be hospitalized than those who were vaccinated, suggests a three-year study of more than 150,000 kidney dialysis patients being...
Fresenius Medical Care North America (FMCNA), the continent's leading provider of kidney care products and services, today announced that the American Society of Nephrology (ASN) accepted a total of 66 abstracts authored by...
DAX leads European markets higher, but London stocks lag on poor earnings reports.
Collaborative Health Systems (CHS), a Universal American company (NYSE: UAM), and Fresenius Medical Care (NYSE: FMS), North America's largest provider of kidney care services, announced an agreement today to provide...
Fresenius Medical Care North America, the leading provider of kidney care products and services across the continent, announced today that its dialysis services business, Fresenius Kidney Care, achieved the country's...
Jimmy Choo shares surge as first-half revenue jumps, Entertainment One plunges.
In response to the Centers for Medicare & Medicaid Services' (CMS) recent Request for Information, Fresenius Medical Care North America issued the following statement: "We welcome the opportunity to provide...